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Abstract
Object: Randomized trials have demonstrated the efficacy of craniectomy for the treatment of malignant cerebral edema
following ischemic stroke. We sought to determine the prevalence and outcomes related to this by using a national
database.
Methods: Patient discharges with ischemic stroke as the primary diagnosis undergoing craniectomy were queried from the
US Nationwide Inpatient Sample from 1999 to 2008. A subpopulation of patients was identified that underwent
thrombolysis. Two primary end points were examined: in-hospital mortality and discharge to home/routine care. To
facilitate interpretations, adjusted prevalence was calculated from the overall prevalence and two age-specific logistic
regression models. The predictive margin was then generated using a multivariate logistic regression model to estimate the
probability of in-hospital mortality after adjustment for admission type, admission source, length of stay, total hospital
charges, chronic comorbidities, and medical complications.
Results: After excluding 71,996 patients with the diagnosis of intracranial hemorrhage and posterior intracranial circulation
occlusion, we identified 4,248,955 adult hospitalizations with ischemic stroke as a primary diagnosis. The estimated rates of
hospitalizations in craniectomy per 10,000 hospitalizations with ischemic stroke increased from 3.9 in 1999–2000 to 14.46 in
2007–2008 (p for linear trend,0.001). Patients 60+ years of age had in-hospital mortality of 44% while the 18–59 year old
group was found to be 24%(p=0.14). Outcomes were comparable if recombinant tissue plasminogen activator had been
administered.
Conclusions: Craniectomy is being increasingly performed for malignant cerebral edema following large territory cerebral
ischemia. We suspect that the increase in the annual incidence of DC for malignant cerebral edema is directly related to the
expanding collection of evidence in randomized trials that the operation is efficacious when performed in the correct
patient population. In hospital mortality is high for all patients undergoing this procedure.
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Introduction
The surgical treatment of life-threatening, space-occupying
cerebral edema following massive middle cerebral artery infarc-
tion, so-called ‘‘malignant’’ infarction, remains a controversial
issue. Historically, there has been a reluctance to perform this
operation given high rate of mortality and profound morbidity
associated with survivors. Until recently, only case series and
nonrandomized case control studies suggested any benefit of
decompressive craniectomy (DC).[1–8] Several recent randomized
controlled trials have demonstrated improved survival and
functional outcome after DC in certain populations. [9–11] The
findings from these randomized controlled trials are recapitulated
in several recent reviews.[3] [12–13] We sought to identify trends
in the prevalence and outcomes of DC for malignant cerebral
infarction using the Nationwide Inpatient Sample (NIS), the
largest all-payer representative sample of the US medical
community.
Methods
We studied the prevalence and outcomes of DC for malignant
cerebral infarction from 1999 to 2008 using data obtained from
the Healthcare Cost and Utilization Project, Agency for
Healthcare Research and Quality (AHRQ) Rockville, MD.[14]
The NIS is a hospital discharge database that represents
approximately 20% of all inpatient admission to non-federal
hospitals in the US. The NIS contains discharge data on 100% of
discharges, an expanding, stratified random sample of 1,044 non-
federal hospitals from 40 states in 2008. Detailed information on
PLoS ONE | www.plosone.org 1 December 2011 | Volume 6 | Issue 12 | e29193the design of the NIS is available at http://www.hcup-us.ahrq.
gov. The NIS includes .100 clinical and non-clinical variables for
each hospital stay. These include diagnoses, procedures, admission
and discharge status, demographics, charges, and lengths of stay.
Patients registered in the NIS from 1999 to 2008 were included
in the analysis. Those with ischemic stroke listed as the primary
diagnosis were identified using the first listed International
Classification of Disease 9th Revision clinical modifier (ICD-9
CM) diagnostic codes 433.11, 433.31, 433.81, 433.91, 434.01,
434.11, 434.91, and 436). Patients with the diagnosis of
intracranial hemorrhage identified by ICD-9 CM diagnostic codes
430, 431, and 432.x were excluded. Also, patients with the
diagnosis of posterior intracranial circulation occlusion (ICD-9
CM diagnostic codes 433.01 & 433.21) were excluded. Then, the
core study population was established by selecting for those also
undergoing craniotomy (including DC), identified by ICD-9 CM
procedure codes 01.24 or 01.25. A subpopulation of the study
population was created using ICD-9 CM procedure code 99.10 to
identify those that received any form of thrombolysis. (As of 2008,
an ICD-9 CM code exists specifically for thrombolysis given at
referring, rather than admitting, hospitals. However, we specifi-
cally did not analyze this due to the absence of the code in the
Figure 1. Trends in intervention procedures among hospitalizations for ischemic stroke* (n=4,248,855). Hospitalizations with ischemic
stroke listed as the primary diagnosis were identified using the first listed International Classification of Disease 9
th Revision clinical modifier (ICD-9
CM) diagnostic codes 433.11, 433.31, 433.81, 433.91, 434.01, 434.11, 434.91, and 436). *Patients with the diagnosis of intracranial hemorrhage (ICD-9
CM diagnostic codes 430, 431, and 432.x) and patients with the diagnosis of posterior intracranial circulation occlusion (ICD-9 CM diagnostic codes
433.01 & 433.21) were excluded. NA: estimates are not reportable due to a small sample size.
doi:10.1371/journal.pone.0029193.g001
Table 1. Trends in intervention procedures among hospitalizations for ischemic stroke* (n=4,248,855), Nationwide Inpatient
Sample, 1999-2008.
1999-00 2001-02 2003-04 2005-06 2007-08
Hospitalizations with ischemic stroke (weighted)
Total hospitalizations 909,064 883,209 830,751 803,241 822,691
Intervention group
DC + rtPA NR 27 36 97 174
DC only 346 316 435 669 1,016
rtPA only 8,374 8,887 10,509 16,850 24,619
DC, overall 351 343 471 766 1,190
Prevalence, per 10,000 hospitalizations with ischemic stroke
DC + rtPA 0.05 (0.00) 0.30 (0.00) 0.43 (0.00) 1.21 (0.00) 2.11 (0.00)
DC only 3.81 (0.01) 3.58 (0.00) 5.24 (0.01) 8.33 (0.01) 12.35 (0.01)
rtPA only 92.11 (0.04) 100.6 (0.05) 126.5 (0.08) 209.8 (0.10) 299.3 (0.11)
DC, overall 3.86 (0.01) 3.88 (0.00) 5.67 (0.01) 9.54 (0.01) 14.46 (0.01)
Hospitalizations with ischemic stroke listed as the primary diagnosis were identified using the first listed International Classification of Disease 9
th Revision clinical
modifier (ICD-9 CM) diagnostic codes 433.11, 433.31, 433.81, 433.91, 434.01, 434.11, 434.91, and 436).
*Patients with the diagnosis of intracranial hemorrhage (ICD-9 CM diagnostic codes 430, 431, and 432.x) and patients with the diagnosis of posterior intracranial
circulation occlusion (ICD-9 CM diagnostic codes 433.01 & 433.21) were excluded.
NR: estimates are not reportable due to a small sample size.
doi:10.1371/journal.pone.0029193.t001
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surgery, dimensions of bony decompression, stroke severity, or
procedure laterality exist in the NIS dataset.
The unit of analysis was the hospital discharge. The rates of DC
per 10,000 hospitalizations with ischemic stroke were assessed
across 5 time intervals: 1999–2000, 200122002, 200322004,
200522006, and 200722008. We have chosen this time frame
since the procedure code for infusion of thrombolytic agent (ICD-
9-CM 99.10) was first introduced in October 1998. Orthogonal
polynomial coefficients were obtained recursively by the method of
Fisher and Yates to test linear trends for the two year intervals.
The rates of DC per 10,000 hospitalizations with ischemic stroke
were also reported between these two age groups: 18–59 and 60+
years. We focused our analysis on these two groups since age is
considered a major prognostic factor of functional recovery after
brain infarction in general (and malignant infarction in particular)
and randomized trials have focused on patient of 60 years and
younger.[15–16] Differences in rates of craniectomy by two age
groups were compared by using chi-square tests.
Patient age, sex, primary payer (public, private, and others),
type of admission (emergency, urgent, elective), admission source
(emergency room, transfer from another hospital, transfer from
long term care, and routine), hospital region (Northeast, Midwest,
South, or West), hospital location and status (urban-teaching,
urban-nonteaching, and rural), and bed size (small, medium,
large), length of stay (days, continuous) and total hospital charges
(US dollars, continuous) were coded in the NIS data. Hospital
charges were converted to United States 2008 dollars using all-
cities Consumer Price Index (http://data.bls.gov/cgi-bin/cpicalc.
pl) Medical comorbidities were defined using markers described by
Elixhauser et al[17] and calculated by use of the AHRQ software
publically available at http://www.hcup-us.ahrq.gov/toolssoft-
ware/comorbidity/comorbidity.jsp. We selected nine co-morbid-
ity conditions (congestive heart failure, peripheral vascular disease,
hypertension, paralysis, other neurological disorders, chronic
pulmonary disease, diabetes with chronic complications, renal
failure and coagulopathy) based on the significance of associations
with in-hospital mortality reported in the previous studies.[18] We
also identified four medical complications by searching the
secondary diagnostic codes (ICD-9-CM codes) for pneumonia,
deep vein thrombosis, pulmonary embolism, and acute myocardial
infarction that were significant predictors of in-hospital mortality
among hospitalizations with ischemic stroke in the same
dataset.[19]
Two primary end points were examined: in-hospital mortality
percentage and discharge to institutions other than home. To
facilitate interpretations, adjusted prevalence was calculated from
the overall and two age-specific logistic regression models using the
PREDMARG statement in SUDAAN.[20] The adjusted percent-
age, also known as predictive margin, was generated using the
logistic regression model to estimate the probability of in-hospital
mortality or probability of home care discharge status, averaging
over the distribution of the covariates among the entire weighted
sample. The reported percentage estimates were adjusted for
survey design as well as the covariates listed above.
Results
During 199922008 we identified 884,729 adult hospitalizations
with ischemic stroke as a primary diagnosis in the NIS, representing
4,320,950 hospitalizations across the United States during this time
period. (Figure 1) After excluding 71,995 patients with the diagnosis
of intracranial hemorrhage and patients with the diagnosis of
posterior intracranial circulation occlusion, our sample size was
4,248,955hospitalizations.Theestimatedratesofhospitalizationsin
DC per 10,000 hospitalizations with ischemic stroke increased from
3.9 in 1999–2000 to 14.46 in 2007–2008 (p for linear trend,0.001)
(Table 1). In 2007–2008, 1 out of 7 hospitalizations with DC also
had performed intravenous thrombolysis with rtPA (recombinant
tissue plasminogen activator). The rates of DC by two age groups
are presented in table 2. The 18–59 year old group had significantly
higher rates compared to 60+ year old group.
Among hospitalizations with ‘‘DC + rtPA’’, in-hospital mortality
was higher among 60+ years old group compared to 18–59 years old
group (44% vs. 24%), although the difference did not reach statistical
significance (p=0.14) (Table 3). However, the difference was not
statistically significant after adjustment for admission type, admission
source, length of stay, total hospital charges, chronic comorbidities,
and medical complications. Among hospitalizations with ‘‘DC only’’,
differences in both unadjusted and adjusted in-hospital mortality rates
between two age groups were highly non-significant.
Among 18–59 years old hospitalizations, no differences existed
for in-hospital mortality and disposition status between ‘‘DC +
Table 2. Numbers and prevalence of decompressive craniectomy with and without rtPA among hospitalizations for ischemic
stroke* by age (n=4,248,955), Nationwide Inpatient Sample, 1999–2008.
Intervention group All 18–59 years 60+ years
Hospitalizations with ischemic stroke (weighted)
DC + rtPA 338 237 101
DC only 2,783 1,784 999
DC, overall 3,121 2,021 1,099
Prevalence, per 10,000 hospitalizations with ischemic stroke
DC + rtPA 0.80 (0.00) 2.99 (0.00) 0.29 (0.00)
DC only 6.55 (0.00) 22.44 (0.01) 2.89 (0.00)
DC, overall 7.35 (0.00) 25.43 (0.02) 3.18 (0.00)
Hospitalizations with ischemic stroke listed as the primary diagnosis were identified using the first listed International Classification of Disease 9
th Revision clinical
modifier (ICD-9 CM) diagnostic codes 433.11, 433.31, 433.81, 433.91, 434.01, 434.11, 434.91, and 436).
*Patients with the diagnosis of intracranial hemorrhage (ICD-9 CM diagnostic codes 430, 431, and 432.x) and patients with the diagnosis of posterior intracranial
circulation occlusion (ICD-9 CM diagnostic codes 433.01 & 433.21) were excluded.
doi:10.1371/journal.pone.0029193.t002
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Among the 60+ year old hospitalization group, ‘‘DC + rtPA’’
group had a higher in-hospital mortalty rate (44% vs. 25%,
respectively) compared to ‘‘DC only’’ group (although the
difference did not reach statistical significance, p=0.14). The
difference became highly non-significant after adjustment for
admission type, admission source, length of stay, total hospital
charges, chronic comorbidities, and medical complications (30%
vs. 26%, p=0.56). In the ‘‘DC + rtPA’’ group, no hospitalizations
with routine/home care disposition status were observed.
Discussion
We studied a population of patients undergoing craniectomy
after inpatient admission for ischemic stroke by using a nationally
representative hospital discharge database. The results of our
Table 3. In-hospital mortality and routine disposition among hospitalizations for ischemic stroke by intervention group and age (N
weighted=3,121), Nationwide Inpatient Sample, 1999–2008.
p-value for difference 18–
59 years vs. 60+
Intervention group All 18–59 years 60+ years
Hospitalizations (weighted)
DC + rtPA 338 237 101
DC only 2,783 1,784 999
DC, overall 3,121 2,021 1,100
In-hospital mortality: Estimated percentage, %
Unadjusted
DC + rtPA 30.39 (0.06) 24.43 (0.06) 43.82 (0.12) .14
DC only 23.39 (0.02) 22.63 (0.02) 24.73 (0.02) .57
p-value for difference
DC + rtPA vs. DC only
.23 .77 .11
Adjusted: Model 1*
DC + rtPA 30.81 (0.06) 24.55 (0.06) 43.13 (0.12) .16
DC only 23.56 (0.02) 22.97 (0.02) 24.75 (0.02) .68
p-value for difference
DC + rtPA vs. DC only
.25 .81 .13
Adjusted: Model 2*
DC + rtPA 26.49 (0.04) 23.79 (0.06) 29.68 (0.07) .56
DC only 23.79 (0.02) 23.00 (0.02) 25.51 (0.03) .53
p-value for difference
DC + rtPA vs. DC only
.56 .89 .59
Routine/home care disposition: Estimated percentage, %
Unadjusted
DC + rtPA 10.31 (0.06) 15.49 0 NA
DC only 11.61 (0.04) 11.76 10.16 .32
p-value for difference
DC + rtPA vs. DC only
.89 .82 NA
Adjusted: Model 1*
DC + rtPA 17.11 (0.06) 24.53 (0.08) 0 NA
DC only 13.11 (0.01) 13.10 (0.02) 13.11 (0.03) .99
p-value for difference
DC + rtPA vs. DC only
.50 .16 NA
Adjusted: Model 2**
DC + rtPA 19.18 (0.06) 26.53 (0.08) 0 NA
DC only 12.69 (0.02) 12.82 (0.02) 12.43 (0.03) .92
p-value for difference
DC + rtPA vs. DC only
.31 .10 NA
*Model 1: Average Marginal Prediction: percentage estimates are adjusted for survey design as well as model covariates (gender, hospital region (Northeast, Midwest,
South, or West), hospital location and status (urban-teaching, urban-nonteaching, and rural), type of admission (emergency, urgent, elective), admission status
(emergency room, transfer from another hospital, transfer from long term care, and routine), payer (public, private, and others), hospital bed size (small, medium, and
large), congestive heart failure, peripheral vascular disease, hypertension, paralysis, other neurological disorders, chronic pulmonary disease, diabetes with chronic
complications, renal failure, coagulopathy, pneumonia, pulmonary embolism, acute myocardial infarction, and deep venous thrombosis.
**Model 2: Average Marginal Prediction: percentage estimates are adjusted for survey design as well as model covariates (all variables in the model 1 + length of stay
(days, continuous) and total charges (US dollars, continuous).
doi:10.1371/journal.pone.0029193.t003
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performed for this condition increased significantly and rapidly
during the studied years, from 1999–2008. This large, inclusive
cohort likely identifies outcomes related to actual practice patterns
rather than those found in carefully selected and controlled
randomized trials.
In the early modern era of neurosurgery, DC was thoughtfully
employed to alleviate elevated intracranial pressure.[21–22] Since
the first use of DC as a specific treatment for the sequelae of stroke
came in 1956, many studies have demonstrated evidence for its
efficacy.[23–26] Although these studies demonstrate increases in
overall survival in selected patients, consideration of quality of life
measures and functional outcomes have limited its use.[3][27] In
recent years, several randomized controlled trials were performed
that demonstrated efficacy of DC for large territory cerebral stroke
in patients generally less than 60 years of age.[9–11] There has
also been evidence to reverse the longstanding dogma that
dominant hemispheric stroke is associated with worse out-
comes.[28–30] We suspect that the increase in the annual
incidence of DC for malignant cerebral edema is directly related
to the expanding collection of evidence in randomized trials that
the operation is efficacious when performed in the correct patient
population.
The pathophysiology of malignant cerebral edema is complex,
but ultimately can be traced to the metabolic and hemodynamic
changes that result in breakdown of the blood brain barrier. [31–
32] Importantly, the use of rtPA in animal models has been shown
to promote disruption of the blood-brain barrier that results in
edema.[33] It is unclear how much the use of rtPA has to do with
the development of malignant cerebral edema in humans. Patients
in the subpopulation of our analysis that received rtPA had a
comparable mortality following DC.[34] Confounding factors not
accounted for when assessing the outcome of DC following rtPA
include bias introduced from variability in stroke severity, access to
care, and clinical presentation that correspond to the guidelines for
safe rtPA administration.[35] In this respect, rtPA administration
can be thought of as a general surrogate marker for these factors.
While in-hospital mortality tended to be higher in the 60+ age
group, adjustment resulted in no identifiable difference between
the two groups. We suspect that this finding relates to the higher
incidence of brain herniation in this population and is heavily
influenced by medical complications & comorbidities across all
ages. The in-hospital mortality associated with surgical interven-
tion is high in this cohort (range =23243%) and comparable to
previously reported randomized trials and metaanalysis when
considering age group.[9–10] [15] While the strength of this study
is its large cohort size, an inherent deficiency is that long term
outcomes, quality of life, and neurological status are unable to be
determined.
It should be noted that a manuscript analyzing the same topic of
DC for stroke was published during the editing phase of this
manuscript. Alshekhlee et al. came to a completely different
conclusion, that the prevalence is the same over a similar time
period. [36] While the same database was analyzed over a slightly
different time period, their analysis only identified 252 patients
undergoing DC (whereas our study identified 3121 patients) for
ischemic stroke. These small numbers, in combination with only
502,231 patients identified as having an acute ischemic stroke,
raises the possibility that the investigators did not perform a valid,
accurate weighted analysis to determine true nationwide estimates.
Limitations of our analysis reflect inherent deficiencies of a
nationwide, administrative database. Although coding for proce-
dures in administrative data have been shown to be reliable,
coding for medical complications and chronic co-morbidities may
be prone to coding bias resulting in high specificity but low
sensitivity selection.[37] Disposition status to home care must be
interpreted with caution as there is no modifier available to denote
situations such as comfort measures or home hospice care. There
is no accounting for the timing of surgery, extent of bony
decompression, stroke severity, or operative laterality in this
dataset.
Conclusion
DC is being increasingly performed for malignant cerebral
edema following large territory cerebral ischemia. We ascertain
that the increase in the annual incidence of DC for malignant
cerebral edema is directly related to the expanding collection of
evidence in randomized trials that the operation is efficacious
when performed in the correct patient population. In hospital
mortality is high for all patients undergoing this procedure, with
the highest being in those greater than 60 years of age.
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